Pfizer Buys into Brazilian Drug Maker Teuto

Oct. 20, 2010
Boosting presence in emerging markets

Pfizer said on Oct. 20 that it has bought 40% of Brazilian drug company Teuto for $238 million as part of its strategy to boost its presence in emerging markets.

The purchase could lead to the 100% acquisition of Teuto in 2014, the company said.

The stake "allows Pfizer to increase its participation in Brazil's pharmaceutical market," the head of Pfizer Brazil, Victor Mezei said. He explained that the deal could result in Teuto producing generic versions of Pfizer medicines, and Pfizer using Teuto products in its output.

The maker of Viagra and Lipitor had 2009 revenues of $50 billion and profits of $8.6 billion.

Copyright Agence France-Presse, 2010

About the Author

Agence France-Presse

Copyright Agence France-Presse, 2002-2024. AFP text, photos, graphics and logos shall not be reproduced, published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP shall not be held liable for any delays, inaccuracies, errors or omissions in any AFP content, or for any actions taken in consequence.

Sponsored Recommendations

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!